Novel enzyme therapy restores hearing in mice with rare genetic bone disorder

Scientists have successfully restored hearing in animal models of ENPP1 deficiency, a genetic disease in which individuals lack an enzyme essential for bone and blood vessel health. The rare disorder can cause hearing loss in as many as 75% of patients who live with it.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup